The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer

Background: The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is hyperactivated in lung cancer and regulates a broad range of cellular processes, including proliferation, survival, angiogenesis, and metastasis. Thus PI3K is considered a promising target for therapy. To date, PI3K inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Chao, Chen, Yin, Li, Hongjian, Yang, Yi, Zhang, Hongtao, Ke, Kunbin, Shi, Xi-Nan, Liu, Xu, Li, Ling, Ma, Jing, Kung, Hsiang-Fu, Chen, Ceshi, Lin, Marie Chia-mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643147/
https://www.ncbi.nlm.nih.gov/pubmed/31337981
http://dx.doi.org/10.7150/ijbs.32625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643147/
https://www.ncbi.nlm.nih.gov/pubmed/31337981
http://dx.doi.org/10.7150/ijbs.32625

Ejemplares similares